Michael Shen has advised high-growth emerging life sciences & technology companies (including Web 3.0 companies) and companies in traditional sectors as well as venture capital, private equity and other firms that invest in those companies on China/US-related corporate and securities transactions, including company formations, spin-offs, venture capital financing, private equity investments, mergers and acquisitions, joint ventures and other strategic transactions, employee equity incentives, corporate governance matters and other general corporate matters.
